Product Information

OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.6295 per EA under NDC 76282070245. Its NADAC has been published 137 times since Apr 10, 2024.

FDA first approved this application on Oct 3, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OSELTAMIVIR PHOS 30 MG CAPSULE

OSELTAMIVIR PHOSPHATE
$0.6295per EA

Strength

30 mg/1

NDC

76282070245

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA217467

FDA Approved

10/3/2023

TE Code

AB

On Market Since

12/1/2023

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 137 times since Apr 10, 2024, and over the history we have for it it has declined 46.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6295 per EA
All-time high$1.1693 (Apr 10, 2024)
All-time low$0.6013 (Aug 20, 2025)
52-week high$0.8323
52-week low$0.6295
Median price$0.7948
Average price$0.8304
Largest weekly change+34.1% (Jun 19, 2024)
Weeks tracked137
Tracking sinceApr 10, 2024

Price History

1W

-2.3%

1M

-7.4%

3M

-9.4%

6M

-16.7%

1Y

-6.5%

3Y

N/A

5Y

N/A

All

-46.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OSELTAMIVIR PHOSPHATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.6295 per EA (NDC 76282070245), effective Nov 18, 2026.

How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 46.2%. It has been tracked across 137 weekly CMS publications since Apr 10, 2024.

What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?

Since Apr 10, 2024, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $1.1693 (Apr 10, 2024), with a median of $0.7948 per EA.

Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?

OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 76282070245) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.